Dilute Stabilized Hypochlorite Solution for Wound Inflammation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for reducing surgical site infections and inflammatory disorders following surgical interventions are inadequate, with existing antimicrobial agents like chlorhexidine and saline showing limited effectiveness, and hypochlorite solutions being deemed too toxic for use on non-infected wounds due to cytotoxicity concerns.

Innovation Solution

A dilute stabilized hypochlorite solution, specifically sodium hypochlorite in concentrations ranging from 0.005-0.2 wt % with sodium chloride and buffered to a pH of 5-11, is used to treat inflammatory responses and conditions in non-infected surgical sites and wounds, offering a novel anti-inflammatory action.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If hypochlorite solution is used to treat inflammatory responses in non-infected wounds, then anti-inflammatory effectiveness is improved, but cytotoxicity and toxicity increase

Engineering Contradiction:
Improveanti-inflammatory effectivenessVSAvoidcytotoxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies parameter changes by precisely controlling the concentration of hypochlorite within a specific range (0.005-0.2 wt%) and buffering the pH to 5-11. This parameter optimization allows the solution to exhibit anti-inflammatory properties while minimizing cytotoxic effects, resolving the contradiction between effectiveness and safety.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses stabilized hypochlorite compounds as intermediaries that mediate the anti-inflammatory response. The stabilized nature of the hypochlorite compound allows it to provide therapeutic benefits while reducing direct cytotoxic damage to cells, acting as a controlled intermediary agent rather than a harsh direct agent.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If higher concentrations of hypochlorite are used, then antimicrobial activity increases, but cytotoxicity and tissue damage increase

Engineering Contradiction:
Improveantimicrobial activityVSAvoidtissue damage
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent fundamentally changes the concentration parameter from traditional high concentrations to a novel low concentration range (0.005-0.2 wt%). This parameter shift demonstrates that effective antimicrobial and anti-inflammatory activity can be achieved at trace concentrations, eliminating the need for high concentrations that cause tissue damage.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If conventional antimicrobial agents like chlorhexidine are used, then surgical site infection prevention is improved, but effectiveness in reducing inflammation and healing time is limited

Engineering Contradiction:
Improveinfection preventionVSAvoidhealing time
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent creates a multi-functional solution where the same hypochlorite-based formulation provides antimicrobial activity, anti-inflammatory effects, and accelerates healing simultaneously. This universal approach replaces the need for separate conventional agents and achieves multiple therapeutic goals with a single treatment, thereby reducing overall healing time.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution effectively reduces healing time, incidence of alveolar osteitis, and improves outcomes for inflammatory skin conditions like eczema and venous leg ulcers by inhibiting inflammatory mediators without the cytotoxicity associated with higher hypochlorite concentrations.

Implementation Method 1

The invention relates to a new approach to the prevention and treatment of inflammation in a mammal... a dilute stabilised hypochlorite solution... for use in the prevention or treatment of an inflammatory response... The solution effectively reduces healing time, incidence of alveolar osteitis, and improves outcomes for inflammatory skin conditions... by inhibiting inflammatory mediators

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS10188676B2Anti-inflammatory solution
Publication Date: 2019.01.29 HYPO STREAM

AI summary

The present invention provides a method for preventing or treating an inflammatory response, condition or disease in a mammal comprising administering an effective amount of a dilute stabilised hypochlorite solution to said mammal in need thereof as well as a means for mixing and administering fresh, dilute stabilised hypochlorite solution to the site where it is needed.